Szakács, D., Kocsis, A., Szász, R., Gál, P., & Pál, G. (2019). Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors. J Biol Chem.
Citação norma ChicagoSzakács, Dávid, Andrea Kocsis, Róbert Szász, Péter Gál, and Gábor Pál. "Novel MASP-2 Inhibitors Developed Via Directed Evolution of Human TFPI1 Are Potent Lectin Pathway Inhibitors." J Biol Chem 2019.
Deismireacht MLASzakács, Dávid, et al. "Novel MASP-2 Inhibitors Developed Via Directed Evolution of Human TFPI1 Are Potent Lectin Pathway Inhibitors." J Biol Chem 2019.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.